Illumina, Inc. (NASDAQ: ILMN) today announced a new spatial technology program that will empower researchers to map complex tissues and understand cellular behavior at an unprecedented scale. Enabled ...
Illumina announces a new NGS-based spatial technology kit and new software platform, Illumina Connected Multiomics.
Illumina Inc (NASDAQ:ILMN)., a leading player in the genomic sequencing industry, finds itself at a critical juncture as it navigates a shifting competitive landscape and global economic challenges.
Gene sequencing machine maker Illumina forecast 2025 revenue largely below Wall Street estimates on Thursday, signaling ...
A stand-alone sequencing approach was accurate, cost effective and efficient for analyzing resistant pathogens and ...
Illumina shares tumbled 8% Friday on investor concerns about the future of the gene-sequencing equipment maker’s business in ...
Illumina is one of Mainboard-listed Venture Corporation’s major customers. Illumina’s shares have fallen some 26.4% over the ...
The placement of Illumina in China's unreliable entity list could have disruptive implications. Read why I remain bullish on ...
Citi analyst Patrick Donnelly lowered the firm’s price target on Illumina (ILMN) to $130 from $165 and keeps a Neutral rating on the shares ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback